Literature DB >> 11518848

Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.

L V González Bosc1, M L Kurnjek, A Müller, N A Terragno, N Basso.   

Abstract

OBJECTIVE: To assess the effect on the cardiovascular system, of enalapril (E) or losartan (L) given since weaning during 6 or 18 months to normal rats.
METHODS: Animals were divided in three groups: control (C), E-treated and L-treated; treated rats received 10 mg/ kg per day of drug. Systolic blood pressure (SBP), body weight, water and food intake (WI, FI), cardiac, left ventricular and aortic weight as well as the length of the tail were recorded. NADPH-diaphorase activity was determined as a marker of nitric oxide synthase (NOS) activity in aorta, arterioles of small intestine, heart and kidney of normal rats. NOS activity was measured as optical density (OD) in the stained tissue. Nitrate + nitrite urinary excretion was measured in 24 h urine. Only significant differences (P < 0.05) are reported.
RESULTS: SBP, absolute cardiac, left ventricular and aortic weight increased with age. Both treatments delayed these increments. At 6 and 18 months, NOS activity was higher in aortic endothelium (Em) of L- and E-treated animals. Losartan treatment during 6 months also increased NOS activity in aortic smooth muscle (SM). Aortic Em NOS activity fell in the 18 months-treated and untreated animals. E increased NOS activity in the SM of intestinal arterioles at 6 months but reduced it at 18 months.
CONCLUSIONS: The fact that both E and L delayed cardiac hypertrophy/hyperplasia and aortic growth and raised aortic endothelium NOS activity indicates a protective effect on cardiovascular damage due to aging, exerted through inhibition of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518848     DOI: 10.1097/00004872-200108000-00008

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

Review 1.  Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging.

Authors:  Debra I Diz
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

Review 2.  Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?

Authors:  Michael J Osgood; David G Harrison; Kevin W Sexton; Kyle M Hocking; Igor V Voskresensky; Padmini Komalavilas; Joyce Cheung-Flynn; Raul J Guzman; Colleen M Brophy
Journal:  Ann Vasc Surg       Date:  2012-03-22       Impact factor: 1.466

3.  Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy.

Authors:  Hye Eun Yoon; Jung Yeon Ghee; ShangGuo Piao; Ji-Hyun Song; Dong He Han; Sol Kim; Naro Ohashi; Hiroyuki Kobori; Makoto Kuro-o; Chul Woo Yang
Journal:  Nephrol Dial Transplant       Date:  2010-09-02       Impact factor: 5.992

Review 4.  Angiotensin receptors as determinants of life span.

Authors:  Paola Cassis; Sara Conti; Giuseppe Remuzzi; Ariela Benigni
Journal:  Pflugers Arch       Date:  2009-09-11       Impact factor: 3.657

5.  Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.

Authors:  Denise M Arrick; Glenda M Sharpe; Hong Sun; William G Mayhan
Journal:  Brain Res       Date:  2008-03-21       Impact factor: 3.252

Review 6.  Age-related changes in redox signaling and VSMC function.

Authors:  Muyao Li; Naomi K Fukagawa
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.